BioNTech SE (BNTX) Stock Forecast
Data as of Sep 18, 2026Healthcare · Current price $97.34 (-1.36%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
BNTX vs Sector & Market
| Metric | BNTX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +21.8% | +16187.2% | +19.5% |
| P/E Ratio | -18.61 | 3.92 | 38.51 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $485M | $1.11B | $2.77B | 2 |
| 2026-12-31 | $335M | $768M | $1.91B | 2 |
| 2027-03-31 | $72M | $165M | $412M | 2 |
| 2027-06-30 | $328M | $751M | $1.87B | 2 |
| 2027-09-30 | $125M | $285M | $711M | 2 |
| 2027-12-31 | $203M | $464M | $1.16B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.18 | $0.69 | $2.03 | 1 |
| 2026-12-31 | $-2.91 | $-0.99 | $-0.27 | 1 |
| 2027-03-31 | $-5.73 | $-1.95 | $-0.52 | 1 |
| 2027-06-30 | $-2.44 | $-0.83 | $-0.22 | 1 |
| 2027-09-30 | $-5.12 | $-1.74 | $-0.47 | 1 |
| 2027-12-31 | $0.20 | $0.76 | $2.23 | 1 |
Frequently Asked Questions
What is the analyst consensus for BNTX?
The consensus among 6 analysts covering BioNTech SE (BNTX) is Buy with an average price target of $129.57.
What is the highest price target for BNTX?
The highest analyst price target for BNTX is $155.00.
What is the lowest price target for BNTX?
The lowest analyst price target for BNTX is $96.00.
How many analysts cover BNTX?
6 analysts have issued ratings for BioNTech SE in the past 12 months.
Is BNTX a buy or sell right now?
Based on 6 analyst ratings, BNTX has a consensus rating of Buy (2.00/5) with a +21.8% upside to the consensus target of $129.57.
What are the earnings estimates for BNTX?
Analysts estimate BNTX will report EPS of $0.69 for the period ending 2026-09-30, with revenue estimated at $1.11B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.